ConductScience.org, home

Paper32899720

Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery.

González-Mora A and 4 others. Vaccines (Basel), 2020. Cited by 79 papers, by iCite.

Cite this record

ConductScience Library. Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery. Papers, record 32899720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32899720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery.
PubMed
Journal
Vaccines (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
79
iCite
Relative citation ratio, by iCite
4.48
iCite
Revised in PubMed
2020-10-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1González-Mora AAlejandrohttps://orcid.org/0000-0002-3605-7522
2Hernández-Pérez JJesúshttps://orcid.org/0000-0001-5413-3245
3Iqbal HMNHafiz M Nhttps://orcid.org/0000-0003-4855-2720
4Rito-Palomares MMarco
5Benavides JJorge

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116556264Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I.Immunology2006https://conductscience.org/library/papers/16556264PubMed
228622860Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV).Vet Microbiol2017https://conductscience.org/library/papers/28622860PubMed
330445702DNA Vaccines-How Far From Clinical Use?Int J Mol Sci2018https://conductscience.org/library/papers/30445702PubMed
429115536Advances in the T7 phage display system (Review).Mol Med Rep2018https://conductscience.org/library/papers/29115536PubMed
520459865Recombinant lambda-phage nanobioparticles for tumor therapy in mice models.Genet Vaccines Ther2010https://conductscience.org/library/papers/20459865PubMed
616029917The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model.Vaccine2005https://conductscience.org/library/papers/16029917PubMed
722015270
Synthetic peptide-targeted selection of phage display mimotopes highlights immunogenic features of α-helical vs non-helical epitopes of Taenia solium paramyosin: implications for parasite- and host-protective roles of the protein.
Peptides2012https://conductscience.org/library/papers/22015270PubMed
820223256Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin.Toxicon2010https://conductscience.org/library/papers/20223256PubMed
912559780Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.Vaccine2003https://conductscience.org/library/papers/12559780PubMed
1023029232Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.PLoS One2012https://conductscience.org/library/papers/23029232PubMed
1110725197Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2.Virology2000https://conductscience.org/library/papers/10725197PubMed
1223251631Cellular internalization mechanism and intracellular trafficking of filamentous M13 phages displaying a cell-penetrating transbody and TAT peptide.PLoS One2012https://conductscience.org/library/papers/23251631PubMed
1322210400Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit vaccine.Vaccine2012https://conductscience.org/library/papers/22210400PubMed
1424442507Bacteriophage lambda display systems: developments and applications.Appl Microbiol Biotechnol2014https://conductscience.org/library/papers/24442507PubMed
1529038472Phage-assisted continuous evolution of proteases with altered substrate specificity.Nat Commun2017https://conductscience.org/library/papers/29038472PubMed
1622906939Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.Hum Vaccin Immunother2012https://conductscience.org/library/papers/22906939PubMed
1722334867Pros and cons of phage therapy.Bacteriophage2011https://conductscience.org/library/papers/22334867PubMed
1818602466Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier.Eur J Pharm Biopharm2008https://conductscience.org/library/papers/18602466PubMed
1919417736Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface.Acta Pharmacol Sin2009https://conductscience.org/library/papers/19417736PubMed
2020056188Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.Vaccine2010https://conductscience.org/library/papers/20056188PubMed

See all 101 referencesDownload CSV of references

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.

PMIDTitleJournalYearIn PapersSource
42931398Phage-Based Vaccine Platforms for Typhoid Fever: A Transformative Approach to Global Health and Antimicrobial Resistance.Vaccines (Basel)2026https://conductscience.org/library/papers/42931398PubMed
42784001SgtrCypB Formulated with Freund's Adjuvant Confers Protective Immunity Against S. globosa and Partial Cross-Protection Against S. schenckii Infections in Mice.J Fungi (Basel)2026https://conductscience.org/library/papers/42784001PubMed
42621610Application of bacteriophages in the prevention and control of bacterial infectious diseases in animals.Front Microbiol2026https://conductscience.org/library/papers/42621610PubMed
42164670Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport.Front Microbiol2026https://conductscience.org/library/papers/42164670PubMed
41901734Cattle Immunization with T7 Phage-Displayed Whole-Tick Antigens Reduces Amblyomma americanum Feeding Efficiency and Blocks Larval Tick Hatching.Pathogens2026https://conductscience.org/library/papers/41901734PubMed
41893819Lambda Phage-Based Antibody-Stimulating Platform Targeting EGFRvIII.Vaccines (Basel)2026https://conductscience.org/library/papers/41893819PubMed
41869406Filamentous Phage for Therapeutic Applications in Non-Small Cell Lung Cancer and Brain Metastases: Recent Prospect.Int J Nanomedicine2026https://conductscience.org/library/papers/41869406PubMed
41814421Host immunogenetic variation and gut microbiome functionality in a wild vertebrate population.Microbiome2026https://conductscience.org/library/papers/41814421PubMed
41401934Bacteriophages as vaccine platforms: Opportunities and challenges in translation.Hum Vaccin Immunother2025https://conductscience.org/library/papers/41401934PubMed
41305429Potential Vaccine or Antimicrobial Reagents: Simple Systems for Producing Lambda Display Particles (LDP) and Sheathed Lambda DNA Vaccine Particles (LDNAP).Viruses2025https://conductscience.org/library/papers/41305429PubMed
41288714Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT.Semin Immunopathol2025https://conductscience.org/library/papers/41288714PubMed
41179940Bacteriophage-based therapies in oral cancer: A new frontier in oncology.Cancer Pathog Ther2025https://conductscience.org/library/papers/41179940PubMed
41025596Engineered bacteriophages for therapeutic and diagnostic applications.Dis Model Mech2025https://conductscience.org/library/papers/41025596PubMed
41012191Advances in Biotechnology and the Development of Novel Human Vaccines.Vaccines (Basel)2025https://conductscience.org/library/papers/41012191PubMed
41012101Role of the Virome in Vaccine-Induced Immunization.Vaccines (Basel)2025https://conductscience.org/library/papers/41012101PubMed
40963058Phage therapy and its role in cancer treatment and control.Folia Microbiol (Praha)2025https://conductscience.org/library/papers/40963058PubMed
40596331Engineering M13 bacteriophage to display HER2 mimotopes on pVIII for vaccine development.Sci Rep2025https://conductscience.org/library/papers/40596331PubMed
40563507Current Efficacy of Multiepitope Vaccines Against Helminths: A Systematic Review.Biomolecules2025https://conductscience.org/library/papers/40563507PubMed
40442309A virus based vaccine combined with IL12 gene therapy eradicates aggressive melanoma.Sci Rep2025https://conductscience.org/library/papers/40442309PubMed
40430931Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives.Pharmaceutics2025https://conductscience.org/library/papers/40430931PubMed

See all 66 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32899720

GET https://conductscience.org/api/papers/v1/32899720/references?page=2